These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 115046)

  • 1. A comparative trial of the decanoates of flupenthixol and fluphenazine.
    Hamilton M; Card IR; Wallis GG; Mahmoud MR
    Psychopharmacology (Berl); 1979 Aug; 64(2):225-9. PubMed ID: 115046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS; Yeo SH
    Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology.
    Wistedt B; Ranta J
    Acta Psychiatr Scand; 1983 Jun; 67(6):378-88. PubMed ID: 6349256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Pinto R; Bannerjee A; Ghosh N
    Acta Psychiatr Scand; 1979 Oct; 60(4):313-22. PubMed ID: 390972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.
    Knights A; Okasha MS; Salih MA; Hirsch SR
    Br J Psychiatry; 1979 Dec; 135():515-23. PubMed ID: 394794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia.
    Kelly HB; Freeman HL; Banning B; Schiff AA
    Int Pharmacopsychiatry; 1977; 12(1):54-64. PubMed ID: 406212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
    Wistedt B
    Acta Psychiatr Scand; 1981 Jul; 64(1):65-84. PubMed ID: 7032224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA
    Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics.
    Wistedt B; Palmstierna T
    J Clin Psychiatry; 1983 Oct; 44(10):369-71. PubMed ID: 6643398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
    Kong DS; Yeo SH
    Singapore Med J; 1985 Dec; 26(7):551-5. PubMed ID: 3834613
    [No Abstract]   [Full Text] [Related]  

  • 11. The problem of post-psychotic schizophrenic depressions and their pharmacological induction. Long-term studies with fluspirilene and penfluridol and single-blind trial with fluphenazine-decanoate and flupenthixol-decanoate.
    Floru L; Heinrich K; Wittek F
    Int Pharmacopsychiatry; 1975; 10(4):230-9. PubMed ID: 814106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
    Ehmann TS; Delva NJ; Beninger RJ
    J Clin Psychopharmacol; 1987 Jun; 7(3):173-5. PubMed ID: 3298328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A depot neuroleptic withdrawal study. Plasma concentration of fluphenazine and flupenthixol and relapse frequency.
    Wistedt B; Jørgensen A; Wiles D
    Psychopharmacology (Berl); 1982; 78(4):301-4. PubMed ID: 6818587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences.
    Johnson DA; Pasterski G; Ludlow JM; Street K; Taylor RD
    Acta Psychiatr Scand; 1983 May; 67(5):339-52. PubMed ID: 6135298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depot fluphenazine and flupenthixol in the treatment of stabilized schizophrenics. A double-blind comparative trial.
    Chowdhury ME; Chacon C
    Compr Psychiatry; 1980; 21(2):135-9. PubMed ID: 6991205
    [No Abstract]   [Full Text] [Related]  

  • 16. Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation.
    Soni SD; Sampath G; Shah A; Krska J
    Acta Psychiatr Scand; 1992 May; 85(5):354-9. PubMed ID: 1351333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluphenazine and flupenthixol decanoate in psychiatric outpatients practice.
    Coufal J; Novotný M
    Act Nerv Super (Praha); 1981 Dec; 23(4):269-71. PubMed ID: 6121439
    [No Abstract]   [Full Text] [Related]  

  • 18. Weight changes with depot neuroleptic maintenance therapy.
    Johnson DA; Breen M
    Acta Psychiatr Scand; 1979 May; 59(5):525-8. PubMed ID: 463589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antipsychotic depot injections in the maintenance treatment of schizophrenia.
    Carney MW; Sheffield BF
    Br J Psychiatry; 1976 Nov; 129():476-81. PubMed ID: 990663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of a 50% reduction of cis(z)-flupenthixol decanoate in chronic schizophrenic patients maintained on a high dose regime.
    Cookson IB
    Int Clin Psychopharmacol; 1987 Apr; 2(2):141-9. PubMed ID: 3298419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.